Internal Medicine, Infectious Disease · Houston, TX
NPI
1023137494
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
6560 Fannin St, Suite 1540
Houston, TX, 77030
Phone (713) 799-9997
Groups this clinician bills Medicare through
Medicare paid, 2024
$97K
1,292 services
Medicare patients, 2024
219
Average age 65
Drug cost, 2024
$1.2M
591 prescriptions
Company payments, 2024
$34.99
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin A Grimes was code 99232 (hospital e&m - subsequent), 817 times for 165 patients. In total Kevin A Grimes billed 1,292 services in 17 codes, and Medicare paid $97K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-04-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 817 | 165 | $60.63 | $50K |
| 99233 Hospital E&M - Subsequent | Facility | 182 | 69 | $90.89 | $17K |
| 99223 Hospital E&M - Initial | Facility | 155 | 137 | $132.97 | $21K |
| 99213 Office E&M - Established | Office | 30 | 25 | $68.63 | $2,059 |
| 99222 Hospital E&M - Initial | Facility | 29 | 28 | $97.45 | $2,826 |
| 99231 Hospital E&M - Subsequent | Facility | 27 | 21 | $36.66 | $990 |
| 99214 Office E&M - Established | Office | 25 | 18 | $86.03 | $2,151 |
By year: 2022 $96K for 1,479 services; 2023 $110K for 1,434 services; 2024 $97K for 1,292 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kevin A Grimes prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 105 prescriptions and refills. In total Kevin A Grimes wrote 591 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 105 | 105 | Under 11 | $419K |
| Juluca Dolutegravir/Rilpivirine | 56 | 56 | Under 11 | $192K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 46 | 46 | Under 11 | $178K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 38 | 38 | Under 11 | $135K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 25 | 39 | Under 11 | $211 |
| Voriconazole Generic | 18 | 18 | Under 11 | $1,529 |
| Valacyclovir Valacyclovir Hcl | 17 | 33 | Under 11 | $992 |
| Amoxicillin Generic | 17 | 31 | Under 11 | $109 |
| Fluconazole Generic | 16 | 20 | Under 11 | $782 |
| Azithromycin Generic | 14 | 14 | Under 11 | $150 |
| Cephalexin Generic | 14 | 14 | Under 11 | $311 |
| Cefepime Hcl Generic | 13 | 13 | Under 11 | $3,950 |
| Ceftazidime Generic | 13 | 13 | Under 11 | $2,387 |
| Dovato Dolutegravir Sodium/Lamivudine | 12 | 12 | Under 11 | $36K |
| Xerava Eravacycline Di-Hydrochloride | 12 | 12 | Under 11 | $8,912 |
Brand drugs: 289 claims; generic drugs: 302 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Kevin A Grimes $34.99 ($34.99 in general payments such as food, travel and fees) from 1 company. The largest payer was Astellas Pharma US Inc with $34.99.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc 4503.T | 1 | $34.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.